Arcads
Rouen-based AI ad generator with 1,000+ AI actors for performance marketing and D2C brands
Quick Overview
| Company | FRESHR |
|---|---|
| Category | AI Video Tools |
| Headquarters | Mont-Saint-Aignan (Rouen), France |
| EU Presence | EU (France) |
| Data Location | EU (France) |
| Open Source | No |
| Compliance | GDPR |
| Free Option | Free trial available |
| Replaces | Creatify, HeyGen, AdCreative.ai |
Detailed Review
Arcads generates the specific format performance marketers run as paid ads: a person talking to camera, UGC-style, but generated from a script and a library of more than 1,000 AI actors rather than filmed. For a D2C brand testing dozens of ad variants a week, that is the actual bottleneck removed — not the editing, but finding and paying a new creator for every script variation to test.
FRESHR, the company behind Arcads, is registered in Mont-Saint-Aignan near Rouen and states in its terms that prices are set in USD, though the amounts themselves are not published on the terms page and were not found elsewhere on the site at the time of writing. A free trial is available before committing to a plan. Translation and localisation across more than 30 languages is included, which matters for a brand running the same ad in several markets.
Against Zebracat, which drafts a broader marketing video from a product link, Arcads is narrower and more specific: one format, one job, done at the volume performance marketing needs. Against Synthesia's stock avatars, Arcads' actor library is built for the UGC look rather than the corporate-presenter look, which is a different register entirely. It is a French company, which places its jurisdiction against HeyGen and Creatify, the two dominant tools in this exact format, both American.
What Arcads does well
- 1,000+ AI actor library built for the UGC ad format
- Script to ad video in minutes, at volume
- Translation and localisation in 30+ languages included
- French company, EU jurisdiction under GDPR
- Free trial available before committing to a plan
Where Arcads falls short
- Exact pricing not published anywhere on the site
- Narrow fit: one ad format, not general video editing
- No disclosed founding date for the product itself
- Competes directly with well-funded American tools in the same niche
Standout feature. A thousand AI actors built for the UGC ad format specifically: Arcads is narrower than Zebracat but built for the exact format performance marketing runs.
Pros and Cons
Pros
- 1,000+ AI actor library built for the UGC ad format
- Script to ad video in minutes, at volume
- Translation and localisation in 30+ languages included
- French company, EU jurisdiction under GDPR
- Free trial available before committing to a plan
Cons
- Exact pricing not published anywhere on the site
- Narrow fit: one ad format, not general video editing
- No disclosed founding date for the product itself
- Competes directly with well-funded American tools in the same niche
Alternatives to Arcads
Frequently Asked Questions
What is Arcads?
Arcads generates the specific format performance marketers run as paid ads: a person talking to camera, UGC-style, but generated from a script and a library of more than 1,000 AI actors rather than filmed. For a D2C brand testing dozens of ad variants a week, that is the actual bottleneck removed — not the editing, but finding and paying a new creator for every script variation to test.
Where is Arcads based?
Arcads operates from Mont-Saint-Aignan (Rouen), France, which places it under EU (France). Compliance: GDPR.
What does Arcads cost?
null. Free trial available.
Who is Arcads best for?
Performance marketers making UGC-style video ads. A thousand AI actors built for the UGC ad format specifically: Arcads is narrower than Zebracat but built for the exact format performance marketing runs.
What are the drawbacks of Arcads?
Exact pricing not published anywhere on the site. Narrow fit: one ad format, not general video editing. No disclosed founding date for the product itself. Competes directly with well-funded American tools in the same niche.